Psychedelics for depression and PTSD | Professor and cognitive neuropsychiatrist Susan Rossell, PhD

Psilocybin Effects

Psilocybin, the active compound in magic mushrooms, is gaining attention for its potential therapeutic effects on mental health disorders. Susan Rossell explains that psilocybin works by opening up the brain to new experiences, which can help individuals with treatment-resistant depression and other conditions like anorexia by breaking their cycle of negative thinking 1. The compound's serotonergic effects differ from typical antidepressants, offering a unique approach to mental health treatment 2. Rossell notes that psilocybin's impact on the brain is profound yet non-addictive, making it a promising candidate for further research 3.

When you take psilocybin, that resting state brain becomes way more activated or way more connected with all the other areas of the brain.

--- Susan Rossell

   

MDMA Therapy

MDMA is emerging as a promising treatment for PTSD, with research indicating positive outcomes for individuals with complex trauma. Susan Rossell highlights that MDMA-assisted therapy is ahead of psilocybin in terms of development and safety protocols, showing mostly positive effects when used under controlled conditions 4. However, she emphasizes the importance of maintaining strict safety guidelines to prevent boundary violations during therapy sessions 5. The therapeutic use of MDMA contrasts with its recreational use, where improper dosing can lead to serotonin depletion and subsequent mood crashes 6.

The effects thus far for people with complex trauma and PTSD have actually been mostly positive.

--- Susan Rossell

   

Psychedelic Impact

The integration of psychedelics into mental health treatment could revolutionize current approaches, offering new hope for those with treatment-resistant conditions. Susan Rossell discusses the potential of psychedelics like psilocybin and MDMA to address mental health crises, particularly where traditional therapies have failed 7. She notes that while psychedelics are not addictive, careful screening is essential to avoid adverse effects in vulnerable individuals 8. Rossell also stresses the importance of combining these treatments with psychotherapy to maximize their benefits and ensure patient safety 9.

We still have people in our clinical trials at the moment have bad trips, and this is one of the reasons why I think, you know, global rollout is years and years away.

--- Susan Rossell